Background and aims This meta-analysis aims to highlight the impact of cardio-metabolic
comorbidities on COVID-19 severity and mortality. Methods A thorough search on major …

Objectives We conducted a systematic literature review and meta-analysis of observational
studies to investigate the association between diabetes, hypertension, body mass index …

Aim To estimate the prevalence of both cardiometabolic and other co‐morbidities in patients
with COVID‐19, and to estimate the increased risk of severity of disease and mortality in …

We examined the effects of coronary heart disease (CHD), hypertension and diabetes on the
development of severe COVID-19. We performed a comprehensive, systematic literature …

ABSTRACT Introduction: Coronavirus disease 2019 (COVID-19) cases are increasing
rapidly worldwide. Similar to Middle East respiratory syndrome where cardiovascular …

Background Estimating the risk of pre-existing comorbidities on coronavirus disease 2019
(COVID-19) mortality may promote the importance of targeting populations at risk to improve …

Background Cardiometabolic disorders may worsen Covid-19 outcomes. We investigated
features and Covid-19 outcomes for patients with or without diabetes, and with or without …

Background and aims Currently there is limited knowledge on medical comorbidities and
COVID-19; we conducted a systematic review and meta-analysis to evaluate the impact of …

ABSTRACT SARS-CoV-2 has caused a worldwide pandemic that began with an outbreak of
pneumonia cases in the Hubei province of China. Knowledge of those most at risk is integral …

Introduction Despite a growing body of scholarly research on the risks of severe COVID-19
associated with diabetes, hypertension and obesity, there is a need for estimating pooled …